Characterization of the human cysteinyl leukotriene CysLT1 receptor

[1]  R. Stocco,et al.  An automated aequorin luminescence-based functional calcium assay for G-protein-coupled receptors. , 1999, Analytical biochemistry.

[2]  R. Doms,et al.  Leukotriene Binding, Signaling, and Analysis of HIV Coreceptor Function in Mouse and Human Leukotriene B4Receptor-transfected Cells* , 1999, The Journal of Biological Chemistry.

[3]  L. F. Kolakowski,et al.  Molecular Characterization and Expression of Cloned Human Galanin Receptors GALR2 and GALR3 , 1998, Journal of neurochemistry.

[4]  L Hendeles,et al.  Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. , 1998, The New England journal of medicine.

[5]  R. Dockhorn,et al.  Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group. , 1998, Archives of internal medicine.

[6]  J. Bernstein,et al.  Montelukast for Chronic Asthma in 6- to 14-Year-Old Children A Randomized, Double-blind Trial , 1998 .

[7]  A. Ford-hutchinson,et al.  Characterization of the recombinant human prostanoid DP receptor and identification of L‐644,698, a novel selective DP agonist , 1998, British journal of pharmacology.

[8]  T. Macdonald,et al.  Characterization of a receptor subtype-selective lysophosphatidic acid mimetic. , 1998, Molecular pharmacology.

[9]  Takao Shimizu,et al.  A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis , 1997, Nature.

[10]  S. Suissa,et al.  Effectiveness of the Leukotriene Receptor Antagonist Zafirlukast for Mild-to-Moderate Asthma , 1997, Annals of Internal Medicine.

[11]  W. Busse,et al.  Results of the first U.S. double-blind, placebo-controlled, multicenter clinical study in asthma with pranlukast, a novel leukotriene receptor antagonist. , 1997, The Journal of asthma : official journal of the Association for the Care of Asthma.

[12]  M. Lerner,et al.  Melanophore pigment dispersion responses to agonists show two patterns of sensitivity to inhibitors of cAMP‐dependent protein kinase and protein kinase C , 1996, Journal of cellular physiology.

[13]  J. Evans,et al.  Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist. , 1995, Canadian journal of physiology and pharmacology.

[14]  J. Drazen,et al.  Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on classification and nomenclature. , 1995, Advances in prostaglandin, thromboxane, and leukotriene research.

[15]  I. Rodger,et al.  Leukotriene D4-induced increases in cytosolic calcium in THP-1 cells: dependence on extracellular calcium and inhibition with selective leukotriene D4 receptor antagonists. , 1994, The Journal of pharmacology and experimental therapeutics.

[16]  M. Potenza,et al.  Functional expression and characterization of human D2 and D3 dopamine receptors , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[17]  K. Lynch,et al.  Responses to sphingosine-1-phosphate in X. laevis oocytes: similarities with lysophosphatidic acid signaling. , 1993, The American journal of physiology.

[18]  R. Zamboni,et al.  Photoaffinity labeling of the leukotriene D4 receptor in guinea pig lung. , 1993, The Journal of biological chemistry.

[19]  D. Nicholson,et al.  Characterization of the leukotriene D4 receptor in dimethylsulphoxide-differentiated U937 cells: comparison with the leukotriene D4 receptor in human lung and guinea-pig lung. , 1993, European journal of pharmacology.

[20]  C. Labat,et al.  A second cysteinyl leukotriene receptor in human lung. , 1992, The Journal of pharmacology and experimental therapeutics.

[21]  Robert A. Lewis,et al.  Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. , 1990, The New England journal of medicine.

[22]  A. Ford-hutchinson,et al.  Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist. , 1989, Canadian journal of physiology and pharmacology.

[23]  D. Lipman,et al.  Improved tools for biological sequence comparison. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[24]  T. Jones,et al.  Effects of l‐serine borate on antagonism of leukotriene C4‐induced contractions of guinea‐pig trachea , 1987, British journal of pharmacology.

[25]  P. Piper.  Formation and actions of leukotrienes. , 1984, Physiological reviews.

[26]  Bengt Samuelsson,et al.  Leukotrienes are potent constrictors of human bronchi , 1980, Nature.